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osting by EAbstract Cimetidine, a histamine H2-receptor, has a structure which enables it to act as a chelating
agent. The formation of nickel(II) complex with cimetidine has been studied spectrophotometrically
at an absorption maximum of 622 nm at different temperatures. The data show that nickel(II) and
cimetidine combine in the molar ratio of 1:2. The stability constants of the complex were calculated
to be 1.40–2.4 · 108 by continuous variation method and 1.24–2.4 · 108 by mole ratio method at 25
and 40 C, respectively. The immediately formed complex shows stability with respect to time and
temperature.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The entire surface of the mammal’s stomach is lined by mu-
cus-secreting cells and 80% of which is comprised of gastric35240697
(F.H. Wattoo).
y. Production and hosting by
Saud University.
lsevierglands. These glands form gastric acid by secreting HCl,
pepsinogen, intrinsic factor and mucus. Hormones like ace-
tylcholine, gastrin and histamine control gastric acid secre-
tion. Speciﬁc receptors present on these secreting cells also
activate HCl-secretion. Histamine stimulates the parietal
cells to release HCl. Minor amounts of histamine are contin-
uously formed by the gastric mucosa with little production
of HCl. Secretions of histamine on parietal cells are H2-
receptors and it is possible to reduce HCl-production by
blocking these receptors. The most commonly used H2-
blocker drugs in human and animals are cimetidine, raniti-
dine, famotidine and nizatadine (Myers, 2006; Tirmizi et
al., 2009, 2010).
Metal ions play a vital role in all living systems and any
malfunctioning of these ions can initiate a number of physio-
logical abnormalities and symptoms of clinical disorders
(Wattoo, 2001). Transition metal ions are responsible for
310 S.A. Tirmizi et al.proper functioning of different enzymes. Researchers have
become increasingly interested in the coordination chemistry
of nickel complexes as models for the active sites in nickel-con-
taining enzymes. This is largely due to the discovery of nickel
at the centers of many important enzymes. Six nickel enzymes
are discovered so for i.e. NiFe hydrogenases, methyl coenzyme
M reductase, carbon monoxide dehydrogenase, acetyl coen-
zyme A synthase and more recently nickel superoxide dismu-
tase (NiSOD). Nickel centers with reversible Ni(II)/Ni(I) and
Ni(III)/Ni(II) couples and low Ni(III)/Ni(II) potentials are
crucial to the activity of these nickel enzymes. Additionally,
there are several proteins required for the delivery and assem-
bly of the nickel ions into the active sites of some of these pro-
teins (Prushan, 2001).
The drug under this study, cimetidine (2-cyano-1-methyl-
3-(2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl)guanidine),
is a histamine H2-receptor antagonist and is used in the
treatment of patients with gastric and duodenal ulcers and
other hypersecretory conditions (Hussain and Habib,
2007). Its chelating ability could result due to the presence
of two electron-donating nitrogen and sulfur atoms sepa-
rated by two carbon atoms (Penston and Wormsley, 1986;
Naveh et al., 1987). The nitrogen and sulfur atoms of cimet-
idine can thus form thermodynamically stable saturated ﬁve-
membered rings by interacting with transition metals (Amigo
et al., 1987; Martinez et al., 1991; Crisponi et al., 1995;
Onoa et al., 2002). Abadia et al. (1986) and Baran and
Proniewicz (1999) reported ﬁrst cimetidine–Ni(II) complexes.
However, to the best of authors knowledge, stability con-
stants of cimetidine–Ni(II) complex at different temperatures
have yet not appeared in the literature. These stability con-
stants are useful to study the effects of cimetidine on trace
elements and mineral metabolism. It is possible that changes
in trace element and mineral concentration induced by
cimetidine might be responsible for drug side effects (Veli-
nov et al., 2001; Silverman, 2004). In the present study,
spectrophotometric methods were used for the determination
of interaction of nickel(II) with cimetidine in acidic medium
and stability constants were determined at 25 and 40 C,
respectively. Structure of cimetidine and possible metal che-
lation is given in Fig. 1.
2. Experimental
2.1. Apparatus
Spectrophotometric measurements were performed on a UV-
1700 Shimadzu double beam spectrophotometer (Japan) using
matched 10 mm quartz cells. A Horiba F.8 pH meter (Spain),
calibrated with standard buffer solutions of pH 4 and 10, was
used for pH measurements.HN
N
H3C
S NH
HN
CH3
N
C
NA B
Figure 1 Structure of (A) cimetidine, (B) model d2.2. Reagents
Cimetidine is marketed under the trade name Tagamet. The
pure sample was gifted by Wilson Pharmaceuticals, Pakistan.
Nickel chloride hexahydrate and all other chemicals used were
of analytical grade purity purchased from Merck Germany.
NiCl2Æ6H2O was taken in an accurate amount and was not fur-
ther standardized. Double-distilled water was used throughout
this study.
2.3. Preparation of 2 · 101 M NiCl2Æ6H2O
NiCl2Æ6H2O (4.76 g, 20 m mol, M. Wt. = 237.7 gmol
1) was
dissolved in freshly distilled and dry ethanol in a beaker and
was made up to the mark in a 100 mL volumetric ﬂask.
2.4. Preparation of 2 · 101 M cimetidine
Cimetidine (5.046 g, 20 m mol, M. Wt. = 252.34 g mol1) was
dissolved in freshly distilled and dry ethanol in a beaker and
was made up to the mark in a 100 mL volumetric ﬂask.
2.5. Procedure for continuous variation method
Nickel(II) (2 · 101 M) chloride hexahydrate solution (0, 1,
2, . . ., 6 mL) was pippeted out and transferred into seven
50 mL volumetric ﬂasks and an aliquot (6, 5, . . ., 0 mL) of
2 · 101 M cimetidine was added, respectively in such a way
that the mole fraction of solution remained constant. Colour
of the solution was changed from light green to light blue.
Wavelength of maximum absorbance was noted against a
blank, which appeared at 622 nm. All the measurements were
made at 622 nm at 25 and 40 C, respectively.
2.6. Procedure for mole ratio method
From 2 · 101 M nickel(II) chloride hexahydrate solution,
2 mL was pippeted out and transferred into each of the seven
50 mL volumetric ﬂasks and an aliquot (1, 2, . . ., 7 mL) of
2 · 101 M cimetidine was added to each, respectively. Wave-
length of maximum absorbance was noted against blank
reagent (nickel(II)chloride hexahydrate), which appeared at
622 nm. All the measurements were made at 622 nm at 25
and 40 C, respectively.
3. Results and discussion
3.1. The properties of complex
The reaction of cimetidine with nickel(II) chloride hexahydrate
was investigated at two different temperatures i.e. 25 andH3C
H
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N
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rawing and (C) metal chelation with cimetidine.
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length range of 400–800 nm. It was found that cimetidine with
nickel(II) chloride hexahydrate formed a light blue, water sol-
uble complex. The complex gave an absorption maximum at
622 nm (series 2 Fig. 2), and was used as kmax for the analytical
measurements. Under the same conditions, pure cimetidine
does not absorb signiﬁcantly over the investigated wavelength
range. However nickel(II) chloride hexahydrate itself absorbs
at 722 nm, which is maximum absorbance kmax (series 1 Fig. 2).
In solution, nickel was present as [Ni(H2O)6]
2+ and showed
kmax at 722 nm. Water behaves as a weak ﬁeld ligand so nickel-
aquo complex acts as a labile complex, which can be easily
replaced by cimetidine, to form a stable complex of stoichiom-
etry ML2 (kmax = 622 nm). Full colour development wasFigure 2 Absorption spectra of nickel(II) chloride hexahydrate
(series 1); and complex with cimetidine (series 2). [C(cimetidine) =
2 · 101 M, C[Ni(H2O)6]Cl2 = 2 · 101 M].
Table 1 Experimental data of nickel(II)–cimetidine complex by con
Sr. No. Metal concentration Ligand concentra
1 0.0 0.24 M= 12 · 10
2 0.04 M= 2 · 104 mole 0.20 M= 10 · 10
3 0.08 M= 4 · 104 mole 0.16 M= 8 · 10
4 0.12 M= 6 · 104 mole 0.12 M= 6 · 10
5 0.16 M= 8 · 104 mole 0.08 M= 4 · 10
6 0.20 M= 10 · 104 mole 0.04 M= 2 · 10
7 0.24 M= 12 · 104 mole 0.0
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Figure 3 Job’s curves for stability constants of equimolar solution
elevations up to 40 C shows no change in Job’s curves.observed immediately and the absorbance remained
unchanged. Metal ion binding is not able to change some
conformational features of cimetidine, which could be a bio-
logically important factor (Silverman, 2004; Sarwar, 2006).
3.2. The composition of complex and stability constant
The stochiometric ratio of cimetidine to Ni(II) in the complex
was determined by Job’s method of equimolar solutions
(Sarwar, 2006). Nickel(II) chloride hexahydrate standard solu-
tions 2 · 101 M were pippetted into seven volumetric ﬂasks
(0, 1, 2, 3, . . ., 6 mL) and an aliquot of 2 · 101 M cimetidine
(6, 5, 4, . . ., 0 mL) was added, respectively keeping the mole
ratio constant. All the measurements were made at 622 nm
at two different temperatures i.e. 25 and 40 C (Table 1).
The curve in Fig. 3 displayed a maximum at a mole fraction
Xmetal = 0.33–0.37, which indicates the formation of complex
having 1:2 metal to ligand ratio.
By applying continuous variation method, also called Job’s
method, the metal to ligand ratio and the stability constant of
the complex have been determined. It requires the series of
solutions of varying concentration of two constituents where
their sum is kept constant. Difference between the measured
absorbance and absorbance is calculated for mixed constitu-
ents on the assumption of no reaction between them, is plotted
against mole fraction. The resulting concentration shows a
maximum at the mole fraction corresponding to their complex.
It is necessary to know the exact concentration of the complex
formed i.e. the exact concentration of the metal ions combined
with ligand and the exact concentration of ligand combined
with metal ions to form a complex. Corresponding equationtinuous variation method.
tion XNi Absorbance at 622 nm
25 C 40 C
4 mole 0.0 0.001 0.001
4 mole 0.17 0.046 0.046
4 mole 0.33 0.078 0.077
4 mole 0.50 0.064 0.066
4 mole 0.66 0.050 0.049
4 mole 0.83 0.034 0.034
1.0 0.016 0.018
XNi
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s at (A) 25 C and (B) 40 C at 622 nm. Note that temperature
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is as following;
KCim ¼ ½ML½M  ½L ð1Þ
KCim ¼ ½A2=A1½1 A2=A1  ½CCim  CNi  A2=A1 ð2Þ
where, A1 = absorbance at break point, A2 = actual absor-
bance, CNi = concentration of nickel and CCim = concentra-
tion of cimetidine.
In Fig. 3, the extrapolated value Aext at the point of cross
section, on the continuous variation plots corresponds to the
total absorbance of the complex, if the complex formation
has been completed. Experimental values of absorbance at dif-
ferent temperatures are given in Table 1. Actually complex is
dissociative in nature and absorbance reading is, therefore,
somewhat lower. From continuous variation curves, A, Aext
and CCim were obtained at different temperatures.
Mole ratio method, another method for determining the
stoichiometry of the complex spectrophotometrically, is espe-
cially applicable to determine stoichiometry of a weak com-
plex. As the complex has metal to ligand ratio that equals
1:2 so the suggested general equation is;
MnþNi þ 2LCim ½ML2 ð3Þ
Ni2þ þ 2Cimetidine ½Ni–Cim2 Complex ð4Þ
By using the mole ratio method, at constant Ni(II)
concentration (4 · 104 moles = 0.08 M) and varying cimeti-
dine concentrations (2 · 104 moles = 0.04 M to 14 · 104Table 2 Experimental data of nickel(II)–cimetidine complex by mo
Sr. No. Metal concentration Ligand co
1 0.08 M= 4 · 104 mole 0.04 M=
2 0.08 M= 4 · 104 mole 0.08 M=
3 0.08 M= 4 · 104 mole 0.12 M=
4 0.08 M= 4 · 104 mole 0.16 M=
5 0.08 M= 4 · 104 mole 0.20 M=
6 0.08 M= 4 · 104 mole 0.24 M=
7 0.08 M= 4 · 104 mole 0.28 M=
0
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Figure 4 Mole ratio method curves for stability constants (A) 25 C
50 C shows no change in curves for mole ratio method.moles = 0.28 M), at kmax = 622 nm and at two different
temperatures i.e. 25 and 40 C (Table 2), a sharp band was
observed at 1:2 mole ratio of Ni(II) to cimetidine (see also
Fig. 4).
The molar absorption coefﬁcient of the complex can be cal-
culated by using the following equation;
A ¼ ekbc ð5Þ
ek ¼ A=bc ð6Þ
A is absorbance at kmax, c is concentration of the metal com-
plex and b is pathlength (I cm). ek is dependent upon wave-
length and is called molar absorption coefﬁcient and has
units of L mol1 cm1. The use of this term speciﬁcally
requires the concentration to be expressed in units of molarity
and sample path length in cm. ek value is quite low which con-
ﬁrms d–d transitions. The corresponding equation (Tirmizi et
al., 2009, 2010), for mole ratio method is as follows:
KCim ¼ ½A=eb½CNi  A=ekb  ½CCim  A=eb ð7Þ
where; ek · b=molar absorptivity constant, and A=
absorbance at peak point.
By applying Mollard method, ﬁrstly at 2.0 · 101 M nicke-
l(II) concentration and excess cimetidine (14 · 104 moles =
0.28 M), the absorbance obtained at 25 C was 0.090 nm,
secondly taking nickel(II) in excess, X0.83 (10 · 104 moles =
0.20 M) and 2 · 104 moles = 0.04 M cimetidine, the absor-
bance at 25 C was 0.034 nm. The results obtained by this
method showed the 1:2 mole ratio of Ni(II)–cimetidine in the
complex.
By applying Job’s and mole ratio methods (Table 3), on the
basis of data obtained, the stability constant has beenle ratio method.
ncentration Absorbance at 622 nm
25 C 40 C
2 · 104 mole 0.020 0.022
4 · 104 mole 0.041 0.042
6 · 104 mole 0.060 0.061
8 · 104 mole 0.081 0.084
10 · 104 mole 0.085 0.088
12 · 104 mole 0.089 0.089
14 · 104 mole 0.090 0.091
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and (B) 40 C at 622 nm. Note that temperature elevations up to
Table 3 Metal–ligand formation constants calculated from continuous variation method and mole ratio method at 25 and 40 C.
Sr. No. Methods Metal:ligand Formation constant (K) at temp (C)
25 C Log K 40 C Log K
1 Continuous variation method 1:2 1.40 · 108 8.15 2.4 · 108 8.30
2 Mole ratio method 1:2 1.24 · 108 8.10 2.4 · 108 8.30
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Figure 5 Stability of nickel(II)–cimetidine complex with respect to (A) time and (B) temperature.
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ent methods are in fair agreement.
3.3. The stability of complex with respect to time and
temperature
Stability of nickel(II)–cimetidine complex with respect to time
and temperature is given in Fig. 5. The colour of the complex
appears immediately after mixing the reactants at any particu-
lar temperature and with the passage of time, no change in the
concentration of the complex or colour intensity was observed,
which shows that there is no effect of time on the complex
concentration.
Similarly, temperature variation does not show any signiﬁ-
cant change in colour intensity of the complex. Stability con-
stant measurements also show that there is no effect of
temperature on the stability constant. There is evidence that
a stable complex is immediately formed by mixing the two re-
agents together at room temperature and on increasing the
temperature no change in colour, intensity and wavelength
of maximum absorption was observed.
Stability constant is a Kinetic Factor. It can be correlated
with DG (free energy), DH (enthalpy), DS (entropy), which
are the thermodynamic factors. They are inter-convertible as
shown here;
KStability ¼ eEactivation=RT ð8Þ
ln KStability ¼ Eactivation
RT
ð9Þ
Eactivation ¼ RT ln KStability ð10Þ
In the present work, we have concentrated only on deter-
mining the stability constants of metal complexes with cimeti-
dine. The composition of the metal complex with H2-receptorand its stability constant can also be determined at different
pH values and in different solvents. Keeping in view objectives
of the present study, we kept in mind the pH and solvent of the
stomach. The pH of stomach is 2.5 (HCl is 1.0 · 102 M) and
solvent is H2O, which is 55.5 M and this was the limitation of
our present work.
4. Conclusion
Cimetidine, an anti ulcer drug, forms a reasonably stable com-
plex with Ni2+. Job’s method of analysis corresponds well with
the analogous values obtained using mole ratio method of anal-
ysis. Owing to a high formation constant at body temperature,
cimetidine intake can remove nickel from the body and this
may disturb the functions of enzymes and can cause anaemia
and weight loss. Nickel deprivation profoundly impairs the
intestinal absorption of iron and thus can cause anaemia.Acknowledgement
We acknowledge the kind gift of cimetidine from Wilson Phar-
maceuticals, Pakistan.
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